122 related articles for article (PubMed ID: 31541801)
1. Rational design of some substituted phenyl azanediyl (bis) methylene phosphonic acid derivatives as potential anticancer agents and imaging probes: Computational inputs, chemical synthesis, radiolabeling, biodistribution and gamma scintigraphy.
Khedr MA; Rashed HM; Farag H; Sakr TM
Bioorg Chem; 2019 Nov; 92():103282. PubMed ID: 31541801
[TBL] [Abstract][Full Text] [Related]
2. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
3. Antifolate and antiproliferative activity of 6,8,10-triazaspiro[4.5]deca-6,8-dienes and 1,3,5-triazaspiro[5.5]undeca-1,3-dienes.
Ma X; Chui WK
Bioorg Med Chem; 2010 Jan; 18(2):737-43. PubMed ID: 20036565
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of novel substituted thiourea derivatives as potential anticancer agents for NSCLC by blocking K-Ras protein-effectors interactions.
Zhang Y; Meng X; Tang H; Cheng M; Yang F; Xu W
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):344-353. PubMed ID: 31851852
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
6. Structure-based virtual screening and biological evaluation of novel non-bisphosphonate farnesyl pyrophosphate synthase inhibitors.
Liu Q; Miao Y; Wang X; Lv G; Peng Y; Li K; Li M; Qiu L; Lin J
Eur J Med Chem; 2020 Jan; 186():111905. PubMed ID: 31785819
[TBL] [Abstract][Full Text] [Related]
7. NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity.
Grimaldi M; Randino R; Ciaglia E; Scrima M; Buonocore M; Stillitano I; Abate M; Covelli V; Tosco A; Gazzerro P; Bifulco M; Rodriquez M; D'Ursi AM
Bioorg Chem; 2020 May; 98():103449. PubMed ID: 32057422
[TBL] [Abstract][Full Text] [Related]
8. Synthesis, Characterization and Evaluation of Cytotoxic Activities of Novel Aziridinyl Phosphonic Acid Derivatives.
Khan R; Ulusan S; Banerjee S; Dogan Ö
Chem Biodivers; 2019 Nov; 16(11):e1900375. PubMed ID: 31512351
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Preliminary Bioactivity Evaluation of 2,7-Substituted Carbazole Derivatives as Potent Autotaxin Inhibitors and Antitumor Agents†.
Wang W; Zhao F; Zhao Y; Pan W; Cao P; Wu L; Wang Z; Zhao X; Zhao Y; Wang H
Anticancer Agents Med Chem; 2019; 19(2):256-264. PubMed ID: 30173652
[TBL] [Abstract][Full Text] [Related]
10. Dual functionality of phosphonic-acid-appended phthalocyanines: inhibitors of urokinase plasminogen activator and anticancer photodynamic agents.
Venkatramaiah N; Pereira PM; Almeida Paz FA; Ribeiro CA; Fernandes R; Tomé JP
Chem Commun (Camb); 2015 Nov; 51(85):15550-3. PubMed ID: 26352730
[TBL] [Abstract][Full Text] [Related]
11. Novel 5-azaindolocarbazoles as cytotoxic agents and Chk1 inhibitors.
Lefoix M; Coudert G; Routier S; Pfeiffer B; Caignard DH; Hickman J; Pierré A; Golsteyn RM; Léonce S; Bossard C; Mérour JY
Bioorg Med Chem; 2008 May; 16(9):5303-21. PubMed ID: 18342518
[TBL] [Abstract][Full Text] [Related]
12. Novel 3-(2-(3-methyl-5-substituted-phenyl-4,5-dihydropyrazol-1-yl)-2-oxoethoxy)-2-substituted-phenyl-4H-chromen-4-one: synthesis and anticancer activity.
Liu XH; Li J; Wu FR; Song BA; Bhadury PS; Shi L
Med Chem; 2011 Nov; 7(6):605-10. PubMed ID: 22313300
[TBL] [Abstract][Full Text] [Related]
13. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
Shi C; Wang J; Chen H; Shi D
J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
[TBL] [Abstract][Full Text] [Related]
14. Azacoccone E inhibits cancer cell growth by targeting 3-phosphoglycerate dehydrogenase.
Guo J; Gu X; Zheng M; Zhang Y; Chen L; Li H
Bioorg Chem; 2019 Jun; 87():16-22. PubMed ID: 30852233
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of anticancer and antiobesity activity of 1-ethoxy carbonyl-3,5-bis (3'-indolyl methylene)-4-pyperidone analogs.
Buduma K; Chinde S; Dommati AK; Sharma P; Shukla A; Srinivas KVNS; Arigari NK; Khan F; Tiwari AK; Grover P; Jonnala KK
Bioorg Med Chem Lett; 2016 Mar; 26(6):1633-1638. PubMed ID: 26873414
[TBL] [Abstract][Full Text] [Related]
16. Diethylalkylsulfonamido(4-methoxyphenyl)methyl)phosphonate/phosphonic acid derivatives act as acid phosphatase inhibitors: synthesis accompanied by experimental and molecular modeling assessments.
Alimoradi N; Ashrafi-Kooshk MR; Shahlaei M; Maghsoudi S; Adibi H; McGeary RP; Khodarahmi R
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):20-28. PubMed ID: 27766897
[TBL] [Abstract][Full Text] [Related]
17. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents.
Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS
Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259
[TBL] [Abstract][Full Text] [Related]
18. Ethenesulfonyl fluoride derivatives as telomerase inhibitors: structure-based design, SAR, and anticancer evaluation in vitro.
Chen X; Zha GF; Wang JQ; Liu XH
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):1266-1270. PubMed ID: 30139286
[TBL] [Abstract][Full Text] [Related]
19. Mechanism-based design, synthesis and biological studies of N⁵-substituted tetrahydrofolate analogs as inhibitors of cobalamin-dependent methionine synthase and potential anticancer agents.
Zhang Z; Tian C; Zhou S; Wang W; Guo Y; Xia J; Liu Z; Wang B; Wang X; Golding BT; Griff RJ; Du Y; Liu J
Eur J Med Chem; 2012 Dec; 58():228-36. PubMed ID: 23124219
[TBL] [Abstract][Full Text] [Related]
20. One-Pot Three-Component Synthesis of Novel Diethyl((2-oxo-1,2-dihydroquinolin-3-yl)(arylamino)methyl)phosphonate as Potential Anticancer Agents.
Fang YL; Wu ZL; Xiao MW; Tang YT; Li KM; Ye J; Xiang JN; Hu AX
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27136538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
